Skip to search formSkip to main contentSkip to account menu

CASC2 gene

Known as: CANCER SUSCEPTIBILITY CANDIDATE 2, CASC2, cancer susceptibility candidate 2 (non-protein coding) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Melanoma is the most malignant and aggressive form of skin carcinoma originating in the pigment-producing melanocytes. In this… 
2018
2018
Our study was aimed to investigate the effect of cancer susceptibility candidate 2 (CASC2) on the proliferation, cell cycle… 
2018
2018
Background/Aims: Long noncoding RNA (lncRNA) cancer susceptibility candidate 2 (CASC2) is downregulated in various cancers and… 
2018
2018
Lnc RNA Cancer Susceptibility Candidate 2(CASC2) has been shown to be aberrantly expressed in multiple types of cancer and might… 
2018
2018
Lung adenocarcinoma is a major form of non–small‐cell lung cancer that frequently strikes nonsmokers. The disease is often… 
2018
2017
2017
ABSTRACT Lung squamous cell carcinoma(LSCC) is the most common and aggressive lung tumor with poor clinical outcome. Previously… 
2016
2016
Long non-coding RNAs (lncRNAs) have been shown to play important roles in tumorigenesis. However, the biological functions and… 
2015
2015
Concentration-optimized CaSc2 O4 :0.2 % Ho(3+) /10 % Yb(3+) shows stronger upconversion luminescence (UCL) than a typical…